The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FcεRIγ-negative NK cells and association with improved outcomes in trastuzumab-treated patients.
 
Vincent Michael Perez
Employment - Tempus
Consulting or Advisory Role - Actym Therapeutics; Arda Therapeutics; BioSkryb Genomics; CytomX Therapeutics; Indapta Therapeutics; Shattuck Labs
 
Sara R. Selitsky
Employment - QuantBio; Sash Biosciences; Tempus
Consulting or Advisory Role - Actym Therapeutics (Inst); Atlas Venture; C4 Therapeutics; Capulus Therapeutics (Inst); Codagenix (Inst); CytomX Therapeutics (Inst); FORMA Therapeutics; GeneCentric; select immunogenomics
 
Bin Yao
Employment - Puma Biotechnology
Stock and Other Ownership Interests - Abbott; Abbvie; Amgen; Gilead Sciences; Merck; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Statagize
 
Austin Bigley
No Relationships to Disclose
 
Sungjin Kim
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Indapta Therapeutics; Therabest
Patents, Royalties, Other Intellectual Property - Michigan State University
 
Mark Walter Frohlich
Employment - Indapta Therapeutics
Leadership - BioEclipse Therapeutics; NEUVOGEN
Stock and Other Ownership Interests - Actym Therapeutics; Artisan Biotechnologies; BioEclipse Therapeutics; Elpis Biopharmaceuticals; Indapta Therapeutics; NEUVOGEN; Strand Therapeutics
Consulting or Advisory Role - Actym Therapeutics; Affini-T Therapeutics; Artisan Biotechnologies; Ellipses Pharma; Strand Therapeutics
Patents, Royalties, Other Intellectual Property - Indapta Therapeutics - novel constructs to augment functionality